Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis.
Batzias K, Antonopoulos AS, Oikonomou E, Siasos G, Bletsa E, Stampouloglou PK, Mistakidi CV, Noutsou M, Katsiki N, Karopoulos P, Charalambous G, Thanopoulou A, Tentolouris N, Tousoulis D. Batzias K, et al. Among authors: tentolouris n. J Diabetes Res. 2018 Dec 4;2018:1232583. doi: 10.1155/2018/1232583. eCollection 2018. J Diabetes Res. 2018. PMID: 30622967 Free PMC article.
Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.
Tentolouris N, Boutati E, Karambakalis N, Perrea D, Tselepis AD, Tsoukala C, Kyriaki D, Lourida E, Anastasopoulou I, Karafoullidou A, Raptis SA, Katsilambros N. Tentolouris N, et al. Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):6-12. doi: 10.1016/j.numecd.2004.06.002. Nutr Metab Cardiovasc Dis. 2005. PMID: 15871845 Clinical Trial.
Cardiovascular effects of glucagon-like peptide 1.
Papazafiropoulou A, Pappas SI, Papadogiannis D, Tentolouris N. Papazafiropoulou A, et al. Among authors: tentolouris n. Mini Rev Med Chem. 2011 Jan;11(1):97-105. doi: 10.2174/138955711793564033. Mini Rev Med Chem. 2011. PMID: 21034402 Review.
Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT).
Knudsen ST, Lapolla A, Schultes B, Tentolouris N, Catarig AM, Wolden ML, Siegmund T. Knudsen ST, et al. Among authors: tentolouris n. Diabet Med. 2019 Jul;36(7):868-877. doi: 10.1111/dme.13976. Epub 2019 May 2. Diabet Med. 2019. PMID: 31001865 Free PMC article.
335 results